Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.

Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca.

OBJECTIVETo isolate and characterize bacteriophage lytic for the opportunistic pathogen Klebsiella oxytoca and their formulation into a vary of solid dosage forms for in-vitro testing.RESULTSWe report the isolation, genomic and practical characterization of a novel bacteriophage lytic for Klebsiella oxytoca, which doesn’t infect the intently associated Klebsiella pneumoniae. This bacteriophage was formulated into suppositories and …

Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca. Read More »